Netlist (NLST) 10-Q 5 Nov 19 2019 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 28, 2019	Oct. 30, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	NETLIST INC
Entity Central Index Key	0001282631
Document Type	10-Q
Document Period End Date	Sep. 28, 2019
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-28
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		164,052,725

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
ASSETS
Cash and cash equivalents	$ 6,386	$ 14,802
Restricted cash	2,250	1,850
Accounts receivable, net of allowances of $43 (2019) and $39 (2018)	2,488	2,917
Inventories	2,398	2,946
Prepaid expenses and other current assets	703	677
Total current assets	14,225	23,192
Property and equipment, net	313	279
Operating lease right-of-use assets	1,133
Other assets	1,375	1,394
Total assets	17,046	24,865
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	8,520	9,497
Revolving line of credit	1,515	2,293
Accrued payroll and related liabilities	475	604
Accrued expenses and other current liabilities	808	343
Convertible promissory note and accrued interest, net	997
Note payable		376
Total current liabilities	12,315	13,113
Convertible promissory note and accrued interest, net	15,665	17,346
Operating lease liabilities	630
Other liabilities	146	78
Total liabilities	28,756	30,537
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.001 par value—10,000 shares authorized: Series A preferred stock, $0.001 par value; 1,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value—300,000 shares authorized; 154,097 (2019) and 139,283 (2018) shares issued and outstanding	154	139
Additional paid-in capital	173,979	169,355
Accumulated deficit	(185,843)	(175,166)
Total stockholders' deficit	(11,710)	(5,672)
Total liabilities and stockholders' deficit	$ 17,046	$ 24,865

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Accounts receivable, allowance for doubtful accounts	$ 43	$ 39
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	154,097,000	139,283,000
Common stock, shares outstanding	154,097,000	139,283,000
Series A Preferred Stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Condensed Consolidated Statements Of Operations
Net sales	$ 6,116	$ 7,203	$ 16,733	$ 24,508
Cost of sales	5,666	6,617	15,600	23,061
Gross profit	450	586	1,133	1,447
Operating expenses:
Research and development	583	535	1,738	2,326
Intellectual property legal fees	979	2,760	3,567	6,359
Selling, general and administrative	1,747	1,745	5,724	5,021
Total operating expenses	3,309	5,040	11,029	13,706
Operating loss	(2,859)	(4,454)	(9,896)	(12,259)
Other expense, net:
Interest expense, net	(245)	(183)	(775)	(463)
Other expense, net	(4)	(7)	(5)	(12)
Total other expense, net	(249)	(190)	(780)	(475)
Loss before provision for income taxes	(3,108)	(4,644)	(10,676)	(12,734)
Provision for income taxes			1
Net loss	$ (3,108)	$ (4,644)	$ (10,677)	$ (12,734)
Net loss per common share:
Basic and diluted	$ (0.02)	$ (0.04)	$ (0.07)	$ (0.13)
Weighted-average common shares outstanding:
Basic and diluted	148,058	115,402	142,624	96,516

Condensed Consolidated Statem_2

Condensed Consolidated Statements Of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 30, 2017	$ 80	$ 152,640	$ (158,046)	$ (5,326)
Balance, shares at Dec. 30, 2017	79,314
Stock-based compensation		241		241
Issuance of common stock, net	$ 5	1,789		1,794
Issuance of common stock, shares	6,101
Net loss			(4,673)	(4,673)
Balance at Mar. 31, 2018	$ 85	154,670	(162,719)	(7,964)
Balance, shares at Mar. 31, 2018	85,415
Balance at Dec. 30, 2017	$ 80	152,640	(158,046)	(5,326)
Balance, shares at Dec. 30, 2017	79,314
Net loss				(12,734)
Balance at Sep. 29, 2018	$ 138	169,176	(170,780)	(1,466)
Balance, shares at Sep. 29, 2018	139,253
Balance at Dec. 30, 2017	$ 80	152,640	(158,046)	(5,326)
Balance, shares at Dec. 30, 2017	79,314
Net loss				17,100
Balance at Dec. 29, 2018	$ 139	169,355	(175,166)	(5,672)
Balance, shares at Dec. 29, 2018	139,283
Balance at Mar. 31, 2018	$ 85	154,670	(162,719)	(7,964)
Balance, shares at Mar. 31, 2018	85,415
Stock-based compensation		173		173
Issuance of common stock, net	$ 17	2,801		2,818
Issuance of common stock, shares	16,393
Restricted stock units vested and distributed, shares	525
Warrants issued in lieu of payments		12		12
Net loss			(3,417)	(3,417)
Balance at Jun. 30, 2018	$ 102	157,656	(166,136)	(8,378)
Balance, shares at Jun. 30, 2018	102,333
Stock-based compensation		157		157
Issuance of common stock, net	$ 36	11,116		11,152
Issuance of common stock, shares	36,920
Warrants issued in lieu of payments		57		57
Estimated fair value of conversion option, in connection with convertible debt		190		190
Net loss			(4,644)	(4,644)
Balance at Sep. 29, 2018	$ 138	169,176	(170,780)	(1,466)
Balance, shares at Sep. 29, 2018	139,253
Balance at Dec. 29, 2018	$ 139	169,355	(175,166)	(5,672)
Balance, shares at Dec. 29, 2018	139,283
Stock-based compensation		342		342
Exercise of stock options		16		16
Exercise of stock options, shares	43
Common stock issued on conversion of Iliad Note	$ 1	374		375
Common stock issued on conversion of Iliad Note (in shares)	1,042
Net loss			(4,050)	(4,050)
Balance at Mar. 30, 2019	$ 140	170,087	(179,216)	(8,989)
Balance, shares at Mar. 30, 2019	140,708
Balance at Dec. 29, 2018	$ 139	169,355	(175,166)	$ (5,672)
Balance, shares at Dec. 29, 2018	139,283
Exercise of stock options, shares				62
Restricted stock units vested and distributed, shares	340
Net loss				$ (10,677)
Balance at Sep. 28, 2019	$ 154	173,979	(185,843)	(11,710)
Balance, shares at Sep. 28, 2019	154,097
Balance at Mar. 30, 2019	$ 140	170,087	(179,216)	(8,989)
Balance, shares at Mar. 30, 2019	140,708
Stock-based compensation		197		197
Exercise of stock options		6		6
Exercise of stock options, shares	19
Tax withholdings related to net share settlements of equity awards (in shares)	(92)
Issuance of commitment shares	$ 1	(1)
Issuance of commitment shares (in shares)	818
Common stock issued on conversion of Iliad Note	$ 1	224		225
Common stock issued on conversion of Iliad Note (in shares)	724
Net loss			(3,519)	(3,519)
Balance at Jun. 29, 2019	$ 142	170,513	(182,735)	(12,080)
Balance, shares at Jun. 29, 2019	142,177
Stock-based compensation		243		243
Issuance of common stock, net	$ 8	2,449		2,457
Issuance of common stock, shares	8,394
Restricted stock units vested and distributed, shares	409
Tax withholdings related to net share settlements of equity awards		(39)		(39)
Tax withholdings related to net share settlements of equity awards (in shares)	(130)
Common stock issued on conversion of Iliad Note	$ 4	813		817
Common stock issued on conversion of Iliad Note (in shares)	3,247
Net loss			(3,108)	(3,108)
Balance at Sep. 28, 2019	$ 154	$ 173,979	$ (185,843)	$ (11,710)
Balance, shares at Sep. 28, 2019	154,097

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018
Cash flows from operating activities:
Net loss	$ (10,677)	$ (12,734)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	132	209
Interest accrued on convertible promissory notes	332	241
Amortization of debt discounts	401	192
Non-cash lease expense	417
Stock-based compensation	782	571
Issuance of warrant in lieu of payment		69
Changes in operating assets and liabilities:
Accounts receivable	429	(229)
Inventories	548	226
Prepaid expenses and other current assets	(7)	142
Accounts payable	(977)	3,534
Accrued payroll and related liabilities	(129)	(304)
Accrued expenses and other current liabilities	(483)	2
Net cash used in operating activities	(9,232)	(8,081)
Cash flows from investing activities:
Acquisition of property and equipment	(70)	(72)
Net cash used in investing activities	(70)	(72)
Cash flows from financing activities:
Net (repayments) borrowings under line of credit	(778)	573
Proceeds from issuance of debt, net of $170 discount		2,100
Debt issuance costs		(23)
Payments on debt	(376)	(344)
Proceeds from issuance of common stock, net	2,457	15,764
Proceeds from exercise of stock options	22
Payments for taxes related to net share settlement of equity awards	(39)
Net cash (used in) provided by financing activities	1,286	18,070
Net change in cash, cash equivalents and restricted cash	(8,016)	9,917
Cash, cash equivalents and restricted cash at beginning of period	16,652	9,520
Cash, cash equivalents and restricted cash at end of period	$ 8,636	$ 19,437

Condensed Consolidated Statem_4

Condensed Consolidated Statements Of Cash Flows (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2018	Sep. 28, 2019
Reconciliation of cash, cash equivalents and restricted cash at end of period:
Original issue discount	$ 170
Cash and cash equivalents	18,187	$ 6,386
Restricted cash	1,250	2,250
Cash, cash equivalents and restricted cash at end of period	$ 19,437	$ 8,636

Description of Business

Description of Business	9 Months Ended
	Sep. 28, 2019
Description of Business
Description of Business	Note 1—Description of Business Netlist, Inc. and its wholly-owned subsidiaries (collectively the “Company” or “Netlist”) provides high-performance modular memory subsystems to customers in diverse industries that require enterprise and storage class memory solutions to empower critical business decisions. The Company has a history of introducing disruptive new products, such as one of the first load-reduced dual in-line memory modules (“LRDIMM”) based on its distributed buffer architecture, which has been adopted by the industry for DDR4 LRDIMM. The Company was also one of the first to bring NAND flash memory (“NAND flash”) to the memory channel with its NVvault non-volatile dual in-line memory modules (“NVDIMM”) using software-intensive controllers and merging dynamic random access memory integrated circuits (“DRAM ICs” or “DRAM”) and NAND flash to solve data bottleneck and data retention challenges encountered in high-performance computing environments. The Company has introduced a new generation of storage class memory products called HybriDIMM™ to address the growing need for real-time analytics in Big Data applications, in-memory databases, high performance computing and advanced data storage solutions. The Company also resells NAND flash, DRAM products and other component products to end-customers that are not reached in the distribution models of the component manufacturers, including storage customers, appliance customers, system builders and cloud and datacenter customers. Due to the ground-breaking product development of its engineering teams, Netlist has built a robust portfolio of over 100 issued and pending U.S. and foreign patents, many seminal, in the areas of hybrid memory, storage class memory, rank multiplication and load reduction. Since its inception, the Company has dedicated substantial resources to the development, protection and enforcement of technology innovations it believes are essential to its business. The Company’s early pioneering work in these areas has been broadly adopted in industry-standard registered dual in-line memory module (“RDIMM”) LRDIMM and NVDIMM. Netlist’s objective is to continue to innovate in its field and invest further in its intellectual property portfolio, with the goal of monetizing its intellectual property through a combination of product sales and licensing, royalty or other revenue-producing arrangements, which may result from joint development or similar partnerships or defense of the Company’s patents through enforcement actions against parties it believes are infringing them. Netlist was incorporated in June 2000 and is headquartered in Irvine, California. The Company has established a manufacturing facility in the People’s Republic of China (“PRC”), which became operational in July 2007. The Company operates in one reportable segment, which is the design and manufacture of high-performance memory subsystems for the server, high-performance computing and communications markets. Liquidity The Company incurred net losses of $3.1 million and $10.7 million for the three and nine months ended September 28, 2019, respectively, and $17.1 million and $13.4 million for the fiscal years ended December 29, On June 24, 2019, the Company entered into a purchase agreement (the “Purchase Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which the Company has the right to sell to Lincoln Park up to an aggregate of $10 million in shares of its common stock over the 36-month term of the Purchase Agreement subject to the conditions and limitations set forth in the Purchase Agreement (see Note 8). Inadequate working capital would have a material adverse effect on the Company’s business and operations and could cause the Company to fail to execute its business plan, fail to take advantage of future opportunities or fail to respond to competitive pressures or customer requirements. A lack of sufficient funding may also require the Company to significantly modify its business model and/or reduce or cease its operations, which could include implementing cost-cutting measures or delaying, scaling back or eliminating some or all of its ongoing and planned investments in corporate infrastructure, research and development projects, business development initiatives and sales and marketing activities, among other activities. While the Company’s estimates of its operating revenues and expenses and working capital requirements could be incorrect and the Company may use its cash resources faster than it anticipates, management believes the Company’s existing cash balance together with cash receipts from revenues, borrowing availability under a bank credit facility (see Note 4), funds available to be raised from the Lincoln Park arrangement (see Note 8) and funds raised through the debt and equity offerings, will be sufficient to meet the Company’s anticipated cash needs for at least the next 12 months.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 28, 2019
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 29, 2018, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 22, 2019. In the opinion of management, all adjustments for the fair presentation of the Company’s condensed consolidated financial statements have been made. The adjustments are of a normal recurring nature except as otherwise noted. The results of operations for the interim periods are not necessarily indicative of the results to be expected for other periods or the full fiscal year. The Company has evaluated events occurring subsequent to September 28, 2019, through the filing date of this Quarterly Report on Form 10-Q and concluded that there were no events that required recognition and disclosures, other than those discussed elsewhere in the notes hereto. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Netlist, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Fiscal Year The Company operates under a 52 or 53 week fiscal year ending on the Saturday closest to December 31. For 2019, the Company’s fiscal year is scheduled to end on December 28, 2019 and will consist of 52 weeks, and each of the Company’s quarters within such fiscal year will be comprised of 13 weeks. Use of Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results may differ materially from those estimates. Revenue Recognition Revenue is recognized when control is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods and services. Revenue recognition is evaluated through the five steps outlined within the guidance. Substantially all of the Company’s net sales relate to products sold at a point in time through ship-and-bill performance obligations. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Contracts with customers are comprised of customer purchase orders, invoices (including the Company’s standard terms and conditions) and written contracts. Performance Obligations Net sales and related cost of sales are primarily the result of promises to transfer products to customers. For performance obligations related to substantially all of the ship-and-bill products, control transfers at a point in time when title transfers upon shipment of the product to the customer, and for some sales, control transfers when title is transferred at time of receipt by the customer. Once a product has shipped or has been delivered, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to have transferred upon shipment or delivery, because the Company has a present right to payment at that time, the customer has legal title to the asset, the Company has transferred physical possession of the asset, and the customer has the significant risks and rewards of ownership of the asset. Amounts billed to its customers for shipping and handling are recorded in net product revenues. Shipping and handling costs incurred by the Company are included in cost of sales in the accompanying condensed consolidated statements of operations. Significant Payment Terms For ship-and-bill type contracts with customers, the invoice states the final terms of the sale, including the description, quantity, and price of each product purchased. Payment terms are typically due within 30 days after delivery but, in limited instances, can range up to 60 days after delivery. Accordingly, the Company’s contracts with customers do not include a significant financing component. Variable Consideration Customers are generally allowed limited rights of return for up to 30 days, except for sales of excess component inventories, which contain no right-of-return privileges. Product returns give rise to variable consideration that decreases the transaction price. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the anticipated performance and all information (historical, current and forecasted) that is reasonably available. Returns for products sold are estimated using the expected value method and are recorded as a reduction in reported revenues at the time of sale based upon historical product return experience and is adjusted for known trends to arrive at the amount of consideration to which the Company expects to receive. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Warranties The Company offers standard product warranties generally ranging from one to three years to its memory subsystem products customers, depending on the negotiated terms of any purchase agreements, and has no other post-shipment obligations or separately priced extended warranty or product maintenance contracts. These warranties require the Company to repair or replace defective product returned to the Company during the warranty period at no cost to the customer. Warranties are not offered on sales of component products. The Company records an estimate for warranty related costs at the time of sale based on its historical and estimated future product return rates and expected repair or replacement costs. Estimated future warranty costs are recorded in the period in which the sale is recorded and are included in cost of sales in the accompanying condensed consolidated statements of operations. Fair Value Measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. The Company categorizes each of its fair value measurements in one of those three levels based on the lowest level input that is significant to the fair value measurement in its entirely. · Level 1 – inputs are based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. · Level 2 – inputs are based on quoted prices of similar instruments in active markets, quoted prices for identical or similar instruments in market that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. · Level 3 – inputs are generally unobservable inputs for the asset or liability, which are typically based on management’s estimates of assumptions that market participants would use in pricing the assets and liabilities. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. The Company’s financial instruments consist principally of cash and cash equivalents, restricted cash, a revolving line of credit, and convertible promissory notes. The Company considers the carrying values of cash and cash equivalents and restricted cash to approximate the fair value for these financial instruments based upon an evaluation of the underlying characteristics, market data and because of the short period of time between origination of the instruments and their expected realization. The Company estimates the fair values of its revolving line of credit and convertible promissory notes by using current applicable rates for similar instruments as of the balance sheet date and an assessment of its credit rating. The carrying value of the Company’s revolving line of credit at September 28, 2019 and December 29, 2018 approximates fair value because the Company’s interest rate yield is near current market rates for comparable debt instruments. The Company estimates the fair value of its convertible promissory notes by using a discounted cash flow analysis using borrowing rates available to the Company for debt instruments with similar terms and maturities. The Company has determined that the valuation of its convertible promissory notes is classified in Level 2 of the fair value hierarchy. The carrying value and estimated fair value of a senior secured convertible promissory note as of September 28, 2019 were $14.5 million and $11.7 million, respectively. The carrying value and estimated fair value of a senior secured convertible promissory note as of December 29, 2018 were $14.3 million and $11.7 million, respectively. The carrying value and estimated fair value of the unsecured convertible note were $1.0 million and $0.7 million, respectively, as of September 28, 2019. The carrying value and estimated fair value of the unsecured convertible note were $2.0 million and $1.7 million, respectively, as of December 29, 2018. Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents, and accounts receivable. The Company invests its cash equivalents primarily in money market mutual funds. Cash equivalents are maintained with high quality institutions, the composition and maturities of which are regularly monitored by management. At times, deposits held with financial institutions may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation and the Securities Investor Protection Corporation. The Company’s trade accounts receivable are primarily derived from sales to OEMs in the server, high-performance computing and communications markets, as well as from sales to storage customers, appliance customers, system builders and cloud and datacenter customers. The Company performs credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary, but generally requires no collateral. The Company believes the concentration of credit risk in its trade receivables is moderated by its credit evaluation process, relatively short collection terms, a high level of credit worthiness of its customers (see Note 3), foreign credit insurance, and letters of credit issued in its favor. Reserves are maintained for potential credit losses, and such losses historically have not been significant and have been within management’s expectations. Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, accrued expenses and other current liabilities, and operating lease liabilities on its condensed consolidated balance sheets. Finance leases are included in property and equipment, accrued expenses and other current liabilities, and other liabilities in its condensed consolidated balance sheets. ROU assets represent the right of the Company to use an underlying asset for the lease term and lease liabilities represent the obligation of the Company to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. The Company does not present short-term leases on the balance sheet, as those leases have a lease term of twelve months or less at inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. Stock-Based Compensation Stock-based awards are comprised principally of stock options, restricted stock and restricted stock units (“RSUs”). Stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period, which is the vesting period, on a straight-line basis, net of estimated forfeitures. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of stock options. The model requires the Company to estimate the expected volatility and expected term of the stock options, which are highly complex and subjective variables. The expected volatility is based on the historical volatility of the Company’s common stock. The expected term is computed using the simplified method as the Company’s best estimate given its lack of actual exercise history. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the expected term of the grant effective as of the date of the grant. The expected dividend assumption is based on the Company’s history and management’s expectation regarding dividend payouts. The grant-date fair value of restricted stock and RSUs equals the closing price of the Company’s common stock on the grant date. Net Loss Per Share The Company computes net loss per share using the two-class method required for participating securities. The Company considers restricted stock awards to be participating securities because holders of such shares have nonforfeitable dividend rights in the event of the Company’s declaration of a dividend for common shares. Under the two-class method, undistributed earnings are allocated to common stock and the participating securities according to their respective participating rights in undistributed earnings, as if all the earnings for the period had been distributed. No allocation of undistributed earnings to participating securities was performed for periods with net losses as such securities do not have a contractual obligation to share in the losses of the Company. Basic net loss per share is calculated by dividing net loss by the weighted-average common shares outstanding during the period following the two-class method. Diluted net loss per share is calculated by dividing the net loss by the weighted-average shares and dilutive potential common shares outstanding during the period. Dilutive potential shares consist of dilutive shares issuable upon the exercise of outstanding stock options and warrants computed using the treasury stock method, shares issuable under the conversion feature of convertible notes using the “if-converted” method, and shares issuable upon the vesting of restricted stock awards. In periods of losses, basic and diluted loss per share are the same, as the effect of stock options, warrants, convertible notes and unvested restricted stock awards on loss per share is anti-dilutive. Adoption of New Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), as amended ("ASC 842"), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. The Company adopted ASC 842 effective December 30, 2018 using a modified retrospective method and did not restate comparative periods. As permitted under the transition guidance, the Company carried forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. The Company also used hindsight in determining lease terms. Based on the lease portfolio as of December 30, 2018, the Company recognized approximately $1.5 million of operating lease right-of-use assets and operating lease liabilities on its condensed consolidated balance sheet upon adoption, primarily relating to real estate. No adjustments were required to be made to accumulated deficit upon adoption. Recently Issued Accounting Pronouncements In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force) , which amends the accounting for implementation, setup, and other upfront costs in a hosting arrangement that is a service contract. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted including adoption in any interim period. The Company does not expect a significant impact as a result of adopting this update on its consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement , which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact as a result of adopting this update on its consolidated financial statements.

Supplemental Financial Informat

Supplemental Financial Information	9 Months Ended
	Sep. 28, 2019
Supplemental Financial Information
Supplemental Financial Information	Note 3—Supplemental Financial Information Inventories Inventories consisted of the following (in thousands): September 28, December 29, 2019 2018 Raw materials $ 843 $ 1,072 Work in process 23 25 Finished goods 1,532 1,849 $ 2,398 $ 2,946 Computation of Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share of common stock (in thousands, except per share data): Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Net loss per share — basic and diluted: Numerator: Net loss $ (3,108) $ (4,644) $ (10,677) $ (12,734) Denominator: Weighted-average common shares outstanding—basic and diluted 148,058 115,402 142,624 96,516 Net loss per share—basic and diluted $ (0.02) $ (0.04) $ (0.07) $ (0.13) No allocation of undistributed earnings to participating securities was performed for periods with net losses as such securities do not have a contractual obligation to share in the losses of the Company. The table below sets forth potentially dilutive weighted average common share equivalents, consisting of shares issuable upon the exercise of outstanding stock options and warrants using the treasury stock method, shares issuable upon conversion of the SVIC Note and the Iliad Note (see Note 5) using the “if-converted” method, and the vesting of restricted stock awards. These potential weighted average common share equivalents have been excluded from the diluted net loss per share calculations above as their effect would be anti-dilutive (in thousands): Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Weighted average common share equivalents 16,120 15,125 16,212 13,506 Disaggregation of Net Sales The following table shows disaggregated net sales by major source (in thousands): Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Resales of third-party products $ 5,180 $ 5,089 $ 13,725 $ 18,531 Sale of the Company's modular memory subsystems 936 2,114 3,008 5,977 Total net sales $ 6,116 $ 7,203 $ 16,733 $ 24,508 Major Customers and Products The Company’s net sales have historically been concentrated in a small number of customers. The following table sets forth the percentage of net sales made to customers that each comprise 10% or more of total net sales: Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Customer: Customer A 13 % 16 % 11 % 19 % Customer B 10 % * % * % * % Customer C * % 12 % * % * % Customer D * % 11 % * % * % Customer E * % 11 % * % * % * The Company’s accounts receivable are concentrated with two customers as of September 28, 2019 representing 14% and 21%, respectively, of aggregate gross receivables. As of December 29, 2018, two customers represented 22% and 15%, respectively, of aggregate gross receivables. The loss of any of the significant customers or a reduction in sales to or difficulties collecting payments from any of these customers could significantly reduce the net sales and adversely affect the operating results of the Company. The Company tries to mitigate risks associated with foreign receivables by purchasing comprehensive foreign credit insurance. The Company resells certain component products to end-customers that are not reached in the distribution models of the component manufacturers, including storage customers, appliance customers, system builders and cloud and datacenter customers. For the three and nine months ended September 28, 2019 and September 29, 2018, resales of these products represented approximately 85%, 82%, 71% and 76%, respectively, of net sales. Cash Flow Information The following table sets forth supplemental disclosure of non-cash financing activities: Nine Months Ended September 28, September 29, 2019 2018 Common stock issued on conversion of convertible note payable and accrued interest $ 1,417 $ — Debt financing of insurance $ — $ 344

Credit Agreements

Credit Agreements	9 Months Ended
	Sep. 28, 2019
Credit Agreements
Credit Agreements	Note 4—Credit Agreement SVB Credit Agreement On October 31, 2009, the Company and Silicon Valley Bank (“SVB”) entered into a credit agreement (as amended, the “SVB Credit Agreement”). Pursuant to the terms of the SVB Credit Agreement, the Company is eligible to borrow, in a revolving line of credit, up to the lesser of (i) 85% of its eligible accounts receivable (increased from 80% as of August 29, 2018), or (ii) $5.0 million, subject to certain adjustments as set forth in the SVB Credit Agreement. The SVB Credit Agreement requires letters of credit to be secured by cash, which is classified as restricted cash in the accompanying condensed consolidated balance sheets. As of September 28, 2019 and December 29, 2018, (i) outstanding letters of credit were $2.3 million and $1.9 million, respectively, (ii) outstanding borrowings were $1.5 million and $2.3 million, respectively, and (iii) availability under the revolving line of credit was $0.1 million and $0.2 million, respectively. On January 29, 2016, the Company and SVB entered into an amendment to the SVB Credit Agreement to, among other things, adjust the rate at which advances under the SVB Credit Agreement accrue interest to the Wall Street Journal “prime rate” plus 2.75% (prior to such amendment, advances accrued interest at a rate equal to SVB’s most recently announced “prime rate” plus 2.75%). On March 27, 2017, the Company and SVB entered into another amendment to the SVB Credit Agreement to, among other things, (i) extend the maturity date of advances under the SVB Credit Agreement to April 1, 2018, (ii) modify the Company’s financial covenants under the SVB Credit Agreement to remove all prior financial standards and replace them with a liquidity ratio standard, (iii) remove or amend certain termination, anniversary and unused facility fees payable by the Company under the SVB Credit Agreement, and (iv) make certain other administrative changes. On April 12, 2017, the Company and SVB entered into a further amendment to the SVB Credit Agreement to, among other things, obtain SVB’s consent in connection with the Company’s rights agreement with Computershare Trust Company, N.A., as rights agent (see Note 8), and make certain administrative changes in connection with the Company’s funding arrangement with TR Global Funding V, LLC, an affiliate of TRGP Capital Management, LLC (“TRGP”) (see Note 7). On March 20, 2018, the Company and SVB entered into another amendment to the SVB Credit Agreement to among other things, (i) extend the maturity date of advances under the SVB Credit Agreement to March 31, 2019 and (ii) revise certain inventory reporting requirements under the SVB Credit Agreement. On August 29, 2018, the SVB Credit Agreement was amended further to increase the borrowing based of accounts receivable to 85% from 80% or $5.0 million, subject to certain adjustments set forth in the SVB Credit Agreement. On March 21, 2019, the SVB Credit Agreement was amended further to (i) extend the maturity date of the advances to March 30, 2020 and (ii) remove the inventory reporting requirements. For all periods before April 20, 2017, all obligations under the SVB Credit Agreement were secured by a first priority security interest in the Company’s tangible and intangible assets, other than its patent portfolio, which was subject to a first priority security interest held by SVIC (see Note 5). Certain of these lien priorities were modified in April and May 2017 in connection with the Company’s establishment of a funding arrangement with TRGP for certain of the Company’s litigation expenses in connection with certain of its legal proceedings against SK hynix, a South Korean memory semiconductor supplier (“SK hynix”). On May 3, 2017, TRGP entered into an intercreditor agreement with each of SVIC and SVB, and on April 20, 2017, SVIC and SVB entered into an intercreditor agreement with each other (such intercreditor agreements, collectively, the “Intercreditor Agreements”). Pursuant to the terms of the Intercreditor Agreements, SVB’s security interests in the Company’s assets have been modified as follows: SVB has a first priority security interest in all of the Company’s tangible and intangible assets other than its patent portfolio and its claims underlying and any proceeds it may receive from the SK hynix proceedings; a second priority security interest in the Company’s patent portfolio other than the patents that are the subject of the SK hynix proceedings; and a third priority security interest in the Company’s patents that are the subject of the SK hynix proceedings (see Note 7). The SVB Credit Agreement subjects the Company to certain affirmative and negative covenants, including financial covenants with respect to the Company’s liquidity and restrictions on the payment of dividends. As of September 28, 2019, the Company was in compliance with its covenants under the SVB Credit Agreement.

Debt

Debt	9 Months Ended
	Sep. 28, 2019
Debt
Debt	Note 5—Debt The Company’s debt consisted of the following (in thousands): September 28, December 29, 2019 2018 Senior secured convertible note, due December 2021, including accrued interest of $1,159 (2019) and $934 (2018), respectively $ 16,159 $ 15,934 Unsecured convertible note, due August 2020, including accrued interest of $1 (2019) and $62 (2018) 1,022 2,332 Note payable — 376 Unamortized debt discounts and issuance costs (519) (920) 16,662 17,722 Less: current portion (997) (376) $ 15,665 $ 17,346 Senior Secured Convertible Note On November 18, 2015, in connection with entering into the JDLA with Samsung, the Company issued to SVIC a Senior Secured Convertible Note (“SVIC Note”) and Stock Purchase Warrant (“SVIC Warrant”). The SVIC Note has an original principal amount of $15.0 million, accrues interest at a rate of 2.0% per year, is due and payable in full on December 31, 2021, and is convertible into shares of the Company’s common stock at a conversion price of $1.25 per share, subject to certain adjustments, on the maturity date of the SVIC Note. Upon a change of control of the Company prior to the maturity date of the SVIC Note, the SVIC Note may, at the Company’s option, be assumed by the surviving entity or be redeemed upon the consummation of such change of control for the principal and accrued but unpaid interest as of the redemption date. The SVIC Warrant grants SVIC a right to purchase 2,000,000 shares of the Company’s common stock at an exercise price of $0.30 per share, subject to certain adjustments, is only exercisable in the event the Company exercises its right to redeem the SVIC Note prior to its maturity date, and expires on December 31, 2025. The SVIC Warrant was valued at $1.2 million, based on its relative fair value, and was recorded as a debt discount. The Company also recorded $0.2 million of debt issuance costs as a debt discount for professional services fees rendered in connection with the transaction. These amounts are being amortized to interest expense over the term of the SVIC Note using the interest method. During the three and nine months ended September 28, 2019 and September 29, 2018, interest expense related to the amortization of the issuance costs associated with the liability component was not material. As of September 28, 2019, the outstanding principal and accrued interest on the SVIC Note was $16.2 million, and the outstanding SVIC Note balance, net of unamortized debt discounts and issuance costs, was $15.7 million. In connection with the SVIC Note, SVIC was granted a first priority security interest in the Company’s patent portfolio and a second priority security interest in all of the Company’s other tangible and intangible assets. Upon issuance of the SVIC Note, the Company, SVB and SVIC entered into an Intercreditor Agreement pursuant to which SVB and SVIC agreed to their relative security interests in the Company’s assets. In May 2017, SVIC, SVB and TRGP entered into additional Intercreditor Agreements to modify certain of these lien priorities (see Note 7). Additionally, upon issuance of the SVIC Note and the SVIC Warrant, the Company and SVIC entered into a Registration Rights Agreement pursuant to which the Company is obligated to register with the SEC, upon demand by SVIC, the shares of the Company’s common stock issuable upon conversion of the SVIC Note or upon exercise of the SVIC Warrant. The SVIC Note subjects the Company to certain affirmative and negative operating covenants. As of September 28, 2019, the Company was in compliance with its covenants under the SVIC Note. Unsecured Convertible Note On August 27, 2018, the Company entered into a Securities Purchase Agreement with Iliad Research and Trading, L.P. (“Iliad”) (the “Iliad Purchase Agreement”), pursuant to which the Company issued a convertible promissory note in the principal amount of $2.3 million (“Iliad Note”) with an original issue discount of $0.2 million. The Iliad Note bears interest at an annual rate of 8% and matures on August 27, 2020, unless earlier repurchased, redeemed or converted in accordance with its terms. The Iliad Note provides Iliad with the right to convert, at any time, all or any part of the outstanding principal and accrued but unpaid interest into shares of the Company’s common stock at a conversion price of $0.36 per share (“Lender Conversion Price”). Further, beginning on April 1, 2019, the Iliad Note also provides Iliad with the right to redeem all or any portion of the Iliad Note (“Redemption Amount”) up to a maximum monthly amount of $0.35 million. The payments of each Redemption Amount may either be made in cash, by converting such Redemption Amount into shares of the Company’s common stock (“Redemption Conversion Shares”), or a combination thereof, at the Company’s election. The number of Redemption Conversion Shares equals the portion of the applicable Redemption Amount being converted divided by the lesser of the Lender Conversion Price or the Market Price, that is 85% of the Company’s lowest closing bid price during the 20 trading days immediately preceding the applicable redemption date (“Redemption Conversion Price”), provided that the Market Price shall not be less than $0.11 per share (the “Redemption Price Floor”). In the event any applicable redemption conversion price is below the Redemption Price Floor then either: (i) the Company will honor the redemption conversion at the then effective redemption conversion price for a Redemption Amount not to exceed $0.15 million if the redemption conversion price is equal to or greater than $0.06 per share or (ii) the Company will pay the applicable Redemption Amount up to $0.15 million in cash and not in Redemption Conversion Shares. The $2.1 million of proceeds received from the issuance of the Iliad Note was initially allocated between long-term debt (the liability component) at $1.9 million and additional paid-in capital (the equity component) at $0.2 million, within the condensed consolidated balance sheet. The carrying amount of the liability component was calculated using the fair value of a similar liability without a conversion feature. The carrying amount of the equity component, representing the conversion option, was determined by deducting the fair value of the liability component from the proceeds received. The amount allocated to the equity component along with the original issue discount and fees paid to Iliad is amortized to interest expense over the expected life of 14 months using the interest method. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The issuance costs incurred related to the issuance of the Iliad Note were not material. As of September 28, 2019, the outstanding principal and accrued interest on the Iliad Note was $1.0 million, and the outstanding Iliad Note balance, net of unamortized debt discounts and issuance costs, was $1.0 million. During the three and nine months ended September 28, 2019, Iliad converted $0.8 million and $0.9 million, respectively, of the outstanding principal and accrued interest on the Iliad Note to 3,247,000 shares and 3,624,074 shares, respectively, of the Company’s common stock at the Redemption Conversion Price. In addition, during the nine months ended September 28, 2019, Iliad converted $0.5 million of the outstanding principal and accrued interest on the Iliad Note to 1,388,890 shares of the Company’s common stock at the Lender Conversion Price. Iliad did not convert any outstanding principal and accrued interest on the Iliad Note at the Lender Conversion Price during the three months ended September 28, 2019. Subsequent to September 28, 2019, Iliad converted $0.7 million of the outstanding principal and accrued interest on the Iliad Note to 2,905,873 shares of the Company’s common stock at the Redemption Conversion Price. The Iliad Note is not secured and does not have any financial covenants requirements for which the Company needs to comply. The Company makes certain customary representations and warranties and has agreed to customary covenants and obligations. The Iliad Purchase Agreement and Iliad Note contain customary events of default upon the occurrence and during the continuance of which all obligations under the Iliad Purchase Agreement and Iliad Note may be declared immediately due and payable.

Leases

Leases	9 Months Ended
	Sep. 28, 2019
Leases
Leases	Note 6—Leases The Company has operating and finance leases primarily associated with office facilities, manufacturing facility and certain equipment. The determination of which discount rate to use when measuring the lease obligation was deemed a significant judgment. Lease cost and supplemental cash flow information related to operating leases was as follows (in thousands): Three Months Ended Nine Months Ended September 28, September 28, 2019 2019 Lease cost Operating lease cost $ 158 $ 476 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 155 $ 450 Right-of-use assets obtained in exchange for lease obligations Finance leases $ — $ 96 For the three and nine months ended September 28, 2019, finance lease costs and cash flows from finance lease were immaterial. Supplemental balance sheet information related to leases was as follows: September 28, (in thousands) 2019 Operating Leases Operating lease right-of-use assets $ 1,133 Accrued expenses and other current liabilities $ 550 Operating lease liabilities 630 Total operating lease liabilities $ 1,180 Finance Leases Property and equipment, at cost $ 96 Accumulated depreciation (9) Property and equipment, net $ 87 Accrued expenses and other current liabilities $ 18 Other long-term liabilities 70 Total finance lease liabilities $ 88 Weighted Average Remaining Lease Term (in years) Operating lease 2.2 Finance lease 4.5 Weighted Average Discount Rate Operating lease 7.7 % Finance lease 5.1 % Maturities of lease liabilities as of September 28, 2019 were as follows (in thousands): Fiscal Year Operating Leases Finance Leases 2019 (remaining 3 months) $ 157 $ 5 2020 596 22 2021 376 22 2022 163 22 2023 — 22 Thereafter — 5 Total lease payments 1,292 98 Less: imputed interest (112) (10) Total $ 1,180 $ 88 A summary of future minimum lease payments under operating lease as of December 29, 2018 was as follows (in thousands): Fiscal Year Amount 2019 $ 399 2020 208 Total minimum lease payments $ 607

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 28, 2019
Commitments and Contingencies
Commitments and Contingencies	Note 7—Commitments and Contingencies TRGP Agreement and Related Intercreditor Agreements On May 3, 2017, the Company and TRGP entered into an investment agreement (the “TRGP Agreement”), which generally provides that TRGP will directly fund the costs incurred by or on behalf of the Company in connection with certain legal proceedings against SK hynix (see “Litigation and Patent Reexaminations” in this Note 7 below), including costs incurred since January 1, 2017 and costs to be incurred in the future in the Company’s first action in the U.S. International Trade Commission (“ITC”) and its U.S. district court proceedings, but excluding the Company’s second ITC action and its proceedings in international courts (all such funded costs, collectively, the “Funded Costs”). In exchange for such funding, the Company has agreed that, if the Company recovers any proceeds in connection with the funded SK hynix proceedings, it will pay to TRGP the amount of the Funded Costs paid by TRGP plus an escalating premium based on when any such proceeds are recovered, such that the premium will equal a specified low-to-mid double-digit percentage of the amount of the Funded Costs and such percentage will increase by a specified low double-digit amount each quarter after a specified date until any such proceeds are recovered. In addition, pursuant to the terms of a separate security agreement between the Company and TRGP dated May 3, 2017 (the “Security Agreement”), the Company has granted to TRGP (i) a first priority lien on, and security in, the claims underlying the funded SK hynix proceedings and any proceeds that may be received by the Company in connection with these proceedings, and (ii) a second priority lien on, and security in, the Company’s patents that are the subject of the funded SK hynix proceedings. The TRGP Agreement does not impose financial covenants on the Company. Termination events under the TRGP Agreement include, among others, any failure by the Company to make payments to TRGP thereunder upon receipt of recoveries in the SK hynix proceedings; the occurrence of certain bankruptcy events; certain breaches by the Company of its covenants under the TRGP Agreement or the related Security Agreement; and the occurrence of a change of control of the Company. If any such termination event occurs, subject to certain cure periods for certain termination events, TRGP would have the right to terminate its obligations under the TRGP Agreement, including its obligation to make any further payments of Funded Costs after the termination date. In the event of any such termination by TRGP, the Company would continue to be obligated to pay TRGP the portion of any proceeds the Company may recover in connection with the SK hynix proceedings that TRGP would have been entitled to receive absent such termination, as described above, and TRGP may also be entitled to seek additional remedies pursuant to the dispute resolution provisions of the TRGP Agreement. In connection with the TRGP Agreement, in May 2017, TRGP, SVIC and SVB entered into the Intercreditor Agreements. Pursuant to the terms of the Intercreditor Agreements, TRGP, SVB and SVIC have agreed to their relative security interest priorities in the Company’s assets, such that: (i) TRGP has a first priority security interest in the Company’s claims underlying the funded SK hynix proceedings and any proceeds that may be received by the Company in connection with these proceedings, and a second priority security interest in the Company’s patents that are the subject of the funded SK hynix proceedings, (ii) SVIC has a first priority security interest in the Company’s complete patent portfolio and a second priority security interest in all of the Company’s other tangible and intangible assets (other than the Company’s claims underlying and any proceeds it may receive from the SK hynix proceedings funded under the TRGP Agreement), and (iii) SVB has a first priority security interest in all of the Company’s tangible and intangible assets other than its patent portfolio and its claims underlying and any proceeds it may receive from the SK hynix proceedings funded under the TRGP Agreement, a second priority security interest in the Company’s patent portfolio other than the patents that are the subject of the SK hynix proceedings funded under the TRGP Agreement, and a third priority security interest in the Company’s patents that are the subject of the SK hynix proceedings funded under the TRGP Agreement. The Company consented and agreed to the terms of each of the Intercreditor Agreements. Legal expenses incurred by the Company but paid by TRGP pursuant to the terms of the TRGP Agreement are excluded from the Company’s consolidated financial statements. During the years ended December 29, 2018 and December 30, 2017, the Company excluded legal expenses of $1.8 million and $10.2 million, respectively, as a result of TRGP’s payment of these expenses under the TRGP Agreement. The Company does not anticipate any further legal expenses will be paid by TRGP under this agreement. During the three and nine months ended September 28, 2019, there were no legal expenses excluded as a result of TRGP’s payment of these expenses under the TRGP Agreement. Any settlement or other cash proceeds the Company may recover in the future in connection with the funded SK hynix proceedings would be reduced by the aggregate amount of legal expenses excluded by the Company as a result of TRGP’s payment of these expenses under the TRGP Agreement, plus the premium amount due to TRGP under the terms of the TRGP Agreement at the time of any such recovery. Litigation and Patent Reexaminations The Company owns numerous patents and continues to seek to grow and strengthen its patent portfolio, which covers various aspects of the Company’s innovations and includes various claim scopes. The Company plans to pursue avenues to monetize its intellectual property portfolio, in which it would generate revenue by selling or licensing its technology, and it intends to vigorously enforce its patent rights against alleged infringers of such rights. The Company dedicates substantial resources to protecting and enforcing its intellectual property rights, including with patent infringement proceedings it files against third parties and defense of its patents against challenges made by way of reexamination and review proceedings at the U.S. Patent and Trademark Office (“USPTO”) and Patent Trial and Appeal Board (“PTAB”). The Company expects these activities to continue for the foreseeable future, with no guarantee that any ongoing or future patent protection or litigation activities will be successful, or that the Company will be able to monetize its intellectual property portfolio. The Company is also subject to litigation based on claims that it has infringed on the intellectual property rights of others. Any litigation, regardless of its outcome, is inherently uncertain, involves a significant dedication of resources, including time and capital, and diverts management’s attention from other activities of the Company. As a result, any current or future infringement claims or patent challenges by or against third parties, whether or not eventually decided in the Company’s favor or settled, could materially adversely affect the Company’s business, financial condition and results of operations. Additionally, the outcome of pending or future litigation and related patent reviews and reexaminations, as well as any delay in their resolution, could affect the Company’s ability to continue to sell its products, protect against competition in the current and expected markets for its products or license or otherwise monetize its intellectual property rights in the future. Google Litigation On December 4, 2009, the Company filed a patent infringement lawsuit against Google, Inc. (“Google”) in the U.S. District Court for the Northern District of California (the “Northern District Court”), seeking damages and injunctive relief based on Google’s alleged infringement of the Company’s U.S. Patent No. 7,619,912 (the “‘912 patent”), which relates generally to technologies to implement rank multiplication. In February 2010, Google answered the Company’s complaint and asserted counterclaims against the Company seeking a declaration that the patent is invalid and not infringed, and claiming that the Company committed fraud, negligent misrepresentation and breach of contract based on the Company’s activities in the Joint Electron Device Engineering Council (“JEDEC”) standard-setting organization. The counterclaim seeks unspecified compensatory damages. Accruals have not been recorded for loss contingencies related to Google’s counterclaim because it is not probable that a loss has been incurred and the amount of any such loss cannot be reasonably estimated. In October 2010, Google requested and was later granted an Inter Partes Reexamination of the ‘912 patent by the USPTO. The reexamination proceedings are described below. In connection with the reexamination request, the Northern District Court granted the Company’s and Google’s joint request to stay the ‘912 patent infringement lawsuit against Google until the completion of the reexamination proceedings . On January 31, 2019, the PTAB, in response to Google’s rehearing request, denied rehearing of the PTAB’s previous decision upholding the validity of claims in Netlist’s ‘912 patent. On April 16, 2019, Google filed an appeal to this decision. Inphi Litigation On September 22, 2009, the Company filed a patent infringement lawsuit against Inphi Corporation (“Inphi”) in the U.S. District Court for the Central District of California (the “Central District Court”). The complaint, as amended, alleges that Inphi is contributorily infringing and actively inducing the infringement of U.S. patents owned by the Company, including the ‘912 patent, U.S. Patent No. 7,532,537 (the “‘537 patent”), which relates generally to memory modules with load isolation and memory domain translation capabilities, and U.S. Patent No. 7,636,274 (the “‘274 patent”), which is related to the ‘537 patent and relates generally to load isolation and memory domain translation technologies. The Company is seeking damages and injunctive relief based on Inphi’s use of the Company’s patented technology. Inphi denied infringement and claimed that the three patents are invalid. In June 2010, Inphi requested and was later granted Inter Partes Reexaminations of the ‘912, ‘537 and ‘274 patents by the USPTO. The reexamination proceedings are described below (except for the reexamination proceeding related to the ‘537 patent, which have concluded with the confirmation of all of the claims of such patent). In connection with the reexamination requests, Inphi filed a motion to stay the patent infringement lawsuit with the Central District Court until completion of the reexamination proceedings, which was granted . On April 16, 2019, Inphi filed an appeal to the PTAB’s January 31, 2019 decision upholding the validity of claims in Netlist’s ‘912 patent. ‘912 Patent Reexamination As noted above, in April 2010, June 2010 and October 2010, Google and Inphi submitted requests for an Inter Partes Reexamination of the ‘912 patent by the USPTO, claiming that the ‘912 patent is invalid and requesting that the USPTO reject the patent’s claims and cancel the patent. Additionally, in October 2010, Smart Modular, Inc. (“Smart Modular”) submitted another such reexamination request. On January 18, 2011, the USPTO granted such reexamination requests, and in February 2011, the USPTO merged the Inphi, Google and Smart Modular ‘912 patent reexaminations into a single proceeding. On March 21, 2014, the USPTO issued an Action Closing Prosecution (“ACP”), an office action that states the USPTO examiner’s position on patentability and closes further prosecution, and on June 18, 2014 the USPTO issued a Right of Appeal Notice (“RAN”), a notice that triggers the rights of the involved parties to file a notice of appeal to the ACP, each of which confirmed the patentability of 92 of the ‘912 patent’s claims and rejected the patent’s 11 other claims. The parties involved filed various notices of appeal, responses and requests, and on November 24, 2015, the PTAB held a hearing on such appeals. On May 31, 2016, the PTAB issued a decision affirming certain of the examiner’s decisions and reversing others. On February 9, 2017, the PTAB granted the Company’s request to reopen prosecution before the USPTO examiner and remanded the consolidated proceeding to the examiner to consider the patentability of certain of the pending claims in view of the PTAB’s May 31, 2016 decision and comments from the parties. On October 3, 2017, the examiner issued a determination as to the patentability of certain of the pending claims, which were found to be unpatentable. On June 1, 2018, the PTAB reversed the Examiner and found the pending amended claims to be patentable. On July 2, 2018, Google requested rehearing of the PTAB’s decision. On January 31, 2019 the PTAB, in response to Google’s rehearing request, denied rehearing of the PTAB’s previous decision upholding the validity of claims in Netlist’s ‘912 patent. On April 16, 2019, Inphi and Google filed an appeal to the ‘912 patent decision. Accruals have not been recorded for loss contingencies related to the ‘912 patent reexamination proceedings because it is not probable that a loss has been incurred and the amount of any such loss cannot be reasonably estimated. ‘627 Patent Reexamination In September 2011, Smart Modular submitted a request for an Inter Partes Reexamination by the USPTO of the Company’s U.S. Patent No. 7,864,627 (the “‘627 patent”), related to the ‘912 patent, alleging that the ‘627 patent is invalid and requesting that the USPTO reject the patent’s claims. On November 16, 2011, the USPTO granted Smart Modular’s request and initiated reexamination. By June 27, 2014, the USPTO’s patent examiner had rejected all of the ‘627 patent’s claims. The Company appealed the examiner’s rejections to the PTAB, and on May 31, 2016, the PTAB issued a decision affirming some of the examiner’s rejections. On July 31, 2016, the Company submitted a request to the PTAB to reopen prosecution before the examiner to amend the claims. On February 9, 2017, the PTAB granted the Company’s request to reopen prosecution and remanded the proceeding to the examiner to consider the patentability of the amended claims in view of the PTAB’s May 31, 2016 decision and comments from Smart Modular. On October 2, 2017, the examiner issued a determination that the amended claims should also be rejected. On June 1, 2018, the PTAB reversed the examiner and found the amended claims to be patentable. Smart Modular did not appeal this latest PTAB decision to the Federal Circuit. On October 3, 2018, the USPTO issued a Notice of Intent to Issue a Reexam Certificate, and on November 5, 2018, the USPTO issued Reexamination Certificate No. 7,864,627 concluding the reexamination. The original ‘627 patent had eighteen claims, and during the reexamination, five were canceled (claims 1, 4, 15, 19, 20) and the remaining fifteen were amended (claims 2, 3, 5-12, 14-18) into their current form as issued in the reexamination certificate. Accruals have not been recorded for loss contingencies related to the ‘627 patent reexamination proceedings because it is not probable that a loss has been incurred and the amount of any such loss cannot be reasonably estimated. ‘274 Patent Reexamination As noted above, in April 2010 and June 2010, Inphi submitted requests for an Inter Partes Reexamination of the ‘274 patent by the USPTO. On August 27, 2010, the request was granted. In March 2012 and June 2012, the USPTO issued an ACP and a RAN, respectively, each of which confirmed the patentability of many of the ‘274 patent’s claims. The parties involved filed various notices of appeal, responses and requests, and on November 20, 2013, the PTAB held a hearing on such appeals. On January 16, 2014, the PTAB issued a decision affirming the examiner in part but reversing the examiner on new grounds and rejecting all of the patent’s claims. On September 11, 2015, the USPTO examiner issued a determination rejecting the amended claims. On January 23, 2017, the USPTO granted-in-part the Company’s petition to enter comments in support of its positions in the proceeding. On May 9, 2017, the PTAB issued a decision on appeal affirming the rejection of all claims. Netlist requested rehearing of the PTAB’s decision on June 6, 2017. The PTAB denied the rehearing request on August 8, 2017. On October 6, 2017, Netlist appealed the decision to the Court of Appeals for the Federal Circuit , which Netlist dismissed on March 19, 2018, thereby terminating the proceedings with the rejection of all ‘274 patent claims becoming final . Accruals have not been recorded for loss contingencies related to the ‘274 patent reexamination proceedings because it is not probable that a loss has been incurred and the amount of any such loss cannot be reasonably estimated . Smart Modular ‘295 Patent Litigation and Reexamination On September 13, 2012, Smart Modular filed a patent infringement lawsuit against the Company in the U.S. District Court for the Eastern District of California (the “Eastern District Court”). The complaint alleges that the Company willfully infringes and actively induces the infringement of certain claims of U.S. Patent No. 8,250,295 (“the ‘295 patent”) issued to Smart Modular and seeks damages and injunctive relief. The Company answered Smart Modular’s complaint in October 2012, denying infringement of the ‘295 patent, asserting that the ‘295 patent is invalid and unenforceable, and asserting counterclaims against Smart Modular. Accruals have not been recorded for loss contingencies related to Smart Modular’s complaint because it is not probable that a loss has been incurred and the amount of any such loss cannot be reasonably estimated . On December 7, 2012, the USPTO granted the Company’s request for the reexamination of the ‘295 patent. On April 29, 2014, the USPTO examiner issued an ACP confirming some claims and rejecting others, and on August 4, 2015, the examiner issued a RAN confirming all pending claims. On September 4, 2015, the Company appealed to the PTAB. The parties involved filed various notices of appeal, responses and requests, and on September 22, 2016, the PTAB held a hearing on such appeals. On November 14, 2016, the PTAB issued a decision reversing the examiner and rejected all of the pending claims. On January 23, 2017, Smart Modular filed a request to reopen prosecution. The parties had the opportunity present evidence and arguments and the examiner issued a determination on May 8, 2017, which found all pending claims to be unpatentable. On December 12, 2017, the PTAB agreed with the examiner and found all pending claims to be unpatentable. Smart Modular appealed the PTAB’s decision to the Court of Appeals for the Federal Circuit. On March 28, 2018, the Eastern District Court stayed the proceedings related to the ‘295 patent . On January 18, 2019, the Company and Smart Modular filed a Joint Motion to Dismiss with Prejudice, terminating the proceedings related to the ‘295 patent in the Eastern District Court. Smart Modular and SanDisk Litigation On July 1 and August 23, 2013, the Company filed complaints against Smart Modular, SMART Storage Systems (which was subsequently acquired by SanDisk Corporation (“SanDisk”)), Smart Worldwide Holdings (“Smart Worldwide”) and Diablo Technologies (“Diablo”) in the Central District Court, seeking, among other things, damages and other relief for alleged infringement of several of the Company’s patents by the defendants based on the manufacture and sale of the ULLtraDIMM memory module, alleged antitrust violations by Smart Modular and Smart Worldwide, and alleged trade secret misappropriation and trademark infringement by Diablo. More particularly, the Company asserted claims from U.S. Patent Nos. 7,881,150; 8,001,434; 8,081,536; 8,301,833; 8,359,501; 8,516,185; and 8,516,187 (the “Asserted Patents”). On August 23, 2013, Smart Modular and Diablo each filed a complaint in the Oakland Division of the Northern District Court seeking declaratory judgment of non-infringement and invalidity of the Asserted Patents. Based on various motions filed by the parties, on November 26, 2013, the Central District Court severed and transferred the patent claims related to the ULLtraDIMM memory module to the Northern District Court. On February 12, 2014, the Northern District Court granted the parties’ joint stipulation dismissing all claims against Smart Modular without prejudice. On April 15, 2014, the Northern District Court granted the parties’ joint stipulation dismissing all claims against Smart Worldwide without prejudice. Between June 18, 2014 and August 23, 2014, SanDisk, Diablo, and Smart Modular filed numerous petitions in the USPTO requesting Inter Partes Review (“IPR”) of the Company’s Asserted Patents. On April 9, 2015, the Northern District Court stayed the proceedings as to the Company’s patent infringement claims pending resolution of all outstanding IPRs. The trade secret misappropriation and trademark infringement claims against Diablo were fully adjudicated on August 17, 2016 (during the pendency of the IPR’s) and are no longer pending. All of the IPRs filed by SanDisk, Diablo and SMART Modular associated with the Asserted Patents with Patent Nos. ending in ‘185, ‘187 and ‘833 have been resolved in the Company’s favor and are no longer pending. The IPRs associated with the Asserted Patents with Patent Nos. ending in ‘150, ‘434, ‘501 and ‘536, and the appeals therefrom, have also concluded, with the Board confirming the patentability of several asserted claims. The litigation, however, remains stayed pending resolution of IPRs filed by Hynix on the same or related patents. On December 8, 2017, Diablo filed for bankruptcy, and on November 9, 2018, the Northern District Court dismissed all claims against Diablo without prejudice. The Company’s patent infringement claims as to all Asserted Patents remain pending against SMART Storage Systems and SanDisk, subject to the stay . SK hynix Litigation On September 1, 2016, the Company filed legal proceedings for patent infringement against SK hynix in the ITC (the “First ITC Action”) and the Central District Court. These proceedings are based on the alleged infringement by SK hynix’s RDIMM and LRDIMM enterprise memory products of six of the Company’s U.S. patents. On October 31, 2017, the Company filed additional legal proceedings for patent infringement against SK hynix in the ITC (the “Second ITC Action”) based on the alleged infringement by SK hynix’s RDIMM and LRDIMM products of two additional U.S. patents owned by the Company. In all of the ITC proceedings, the Company has requested exclusion orders that direct U.S. Customs and Border Protection to stop allegedly infringing SK hynix RDIMM and LRDIMM products from entering the United States. In the Central District Court proceedings, the Company is primarily seeking damages . On October 3, 2016, the ITC instituted an investigation of the trade practices of SK hynix and certain of its subsidiaries in connection with the First ITC Action, and held a hearing on the merits of the investigation from May 8, 2017 until May 11, 2017. On November 14, 2017, the ITC issued a final initial determination for the First ITC Action, finding no infringement of the asserted patents and no violation of Section 337 of the Tariff Act, and on January 16, 2018, the ITC issued a final determination for the First ITC Action, affirming the findings of no infringement and no violation and terminating the investigation. The Company is appealing this final determination to the Court of Appeals for the Federal Circuit with a hearing scheduled for December 5, 2019. On January 11, 2018, the ITC set a 19-month target date of July 3, 2019 for an investigation related to the Second ITC Action, with a final initial determination for the Second ITC Action being filed no later than March 1, 2019. Based on this target date, the ITC scheduled a hearing on the merits of the investigation related to the Second ITC Action to begin on November 9, 2018 and conclude on November 19, 2018. On April 12, 2018, the ITC granted SK hynix’s motion for summary determination of non-infringement and terminated the Second ITC Action in its entirety. On April 23, 2018, the Company filed a petition seeking ITC review of this decision. On May 29, 2018, the ITC Commission remanded the Second ITC Action back to the Administrative Law Judge (“ALJ”) to resolve the parties’ claim construction disputes and continue the investigation. On June 14, 2018, the ITC extended the target date for the final determination to August 5, 2019, with a final initial determination due by April 5, 2019. Based on this extended target date, the ITC scheduled a hearing on the merits to begin on December 14, 2018 and conclude on December 21, 2018. On September 13, 2018, the ITC rescheduled the hearing on the merits to begin on January 14, 2019 and conclude on January 18, 2019. On January 29, 2019, due to the government shutdown, the ITC again rescheduled the hearing on the merits to begin on March 11, 2019 and conclude on March 15, 2019. On February 8, 2019, Chief Administrative Law Judge of the ITC issued an Order in Investigation No. 337-TA-1089 denying SK hynix’s motion for “Summary Determination of Non Infringement of Netlist’s U.S. Patent No. 9,535,623 Based On Issue Preclusion.” On March 12, 2019, the ALJ postponed the trial due to reasons unrelated to the dispute between the parties. The trial recommenced on July 15, 2019 and ended on July 19, 2019. On October 21, 2019, the ITC issued an initial determination for the Second ITC Action, finding infringement by SK hynix of asserted Netlist U.S. Patent No. 9,606,907 (the “‘907 Patent”) resulting in a violation of Section 337 of the Tariff Act. The final determination by the ITC will be rendered on February 21, 2020. Between December 30, 2016 and January 20, 2017, SK hynix filed numerous petitions in the USPTO requesting IPR of certain of the Company’s patents, including the patents asserted in the First ITC Action and the Central District Court proceedings, which have now concluded and certain of which are now on appeal to the Court of Appeals for the Federal Circuit. Between December 19, 2017 and February 7, 2018, SK hynix filed additional petitions in the USPTO requesting IPR of the patents asserted in the Second ITC Action which are now proceeding. On March 21, 2019, the PTAB issued a Final Written Decision finding Netlist’s U.S. Patent No. 9,535,623 invalid. Netlist has filed notice of intent to appeal. On June 27, 2019, the PTAB issued Final Written Decisions on two IPR proceedings regarding Netlist’s U.S. Patent No. 9,606,907 (the “‘907 Patent”) based on the reference Ellsberry, holding that claims 1-39 and 42-65 of the ‘907 Patent are unpatentable, but claims 40 and 41 are not unpatentable. On July 12, 2019, Netlist filed a Motion to Terminate under 35 U.S.C. § 315(e)(1) the remaining two IPR proceedings regarding the ‘907 Patent based on the references Halbert and Amidi. On July 19, 2019, SK hynix filed and served their opposition to Netlist’s Motion To Terminate. The PTAB issued a decision to Terminate IPR IPR2018-0036 on August 5, 2019. On July 17, 2017, the Central District Court granted in part SK hynix’s request to stay the infringement proceedings pending further order of the court. On July 11, 2017, the Company filed legal proceedings for patent infringement against SK hynix and certain of its distributors in the courts of Germany and the PRC based on the alleged infringement by SK hynix’s LRDIMM products of certain of the Company’s patents in those jurisdictions. On January 25, 2018, the court in Germany held a preliminary hearing and then held the trial on December 6, 2018. In December 2017, SK hynix filed petitions challenging the validity of the patents asserted by the Company in Germany and the PRC. On June 3, 2018, the patent asserted in the PRC was found to be invalid. On June 19, 2018, the Company withdrew the patent infringement suits filed in the PRC. On January 31, 2019, the court in Germany dismissed the infringement action, and ordered the Company to bear the costs of the action. Netlist has elected not to appeal the German court’s finding. Other Contingent Obligations In the ordinary course of its business, the Company has made certain indemnities, commitments and guarantees pursuant to which it may be required to make payments in relation to certain transactions. These include, among others: (i) intellectual property indemnities to the Company’s customers and licensees in connection with the use, sale and/or license of Company products; (ii) indemnities to vendors and service providers pertaining to claims based on the Company’s negligence or willful misconduct; (iii) indemnities involving the accuracy of representations and warranties in certain contracts; (iv) indemnities to directors and officers of the Company to the maximum extent permitted under the laws of the State of Delaware; (v) indemnities to TRGP, SVIC, SVB and Iliad pertaining to all obligations, demands, claims, and liabilities claimed or asserted by any other party in connection with transactions contemplated by the applicable investment or loan documents, as applicable; and (vi) indemnities or other claims related to certain real estate leases, under which the Company may be required to indemnify property owners for environmental and other liabilities or may face other claims arising from the Company’s use of the applicable premises. The duration of these indemnities, commitments and guarantees varies and, in certain cases, may be indefinite. The majority of these indemnities, commitments and guarantees do not provide for any limitation of the maximum potential for future payments the Company could be obligated to make. Historically, the Company has not been obligated to make significant payments as a result of these obligations, and no liabilities have been recorded for these indemnities, commitments and guarantees in the accompanying condensed consolidated balance sheets.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 28, 2019
Stockholders' Equity
Stockholders' Equity	Note 8—Stockholders’ Equity Serial Preferred Stock The Company’s authorized capital stock includes 10,000,000 shares of serial preferred stock, with a par value of $0.001 per share. No shares of preferred stock were outstanding at September 28, 2019 or December 29, 2018. On April 17, 2017, the Company entered into a rights agreement (the “Rights Agreement”) with Computershare Trust Company, N.A., as rights agent. In connection with the adoption of the Rights Agreement and pursuant to its terms, the Company’s board of directors authorized and declared a dividend of one right (each, a “Right”) for each outstanding share of the Company’s common stock to stockholders of record at the close of business on May 18, 2017 (the “Record Date”), and authorized the issuance of one Right for each share of the Company’s common stock issued by the Company (except as otherwise provided in the Rights Agreement) between the Record Date and the Distribution Date (as defined below) . Each Right entitles the registered holder, subject to the terms of the Rights Agreement, to purchase from the Company, when exercisable and subject to adjustment, one unit consisting of one one-thousandth of a share (a “Unit”) of Series A Preferred Stock of the Company (the “Preferred Stock”), at a purchase price of $6.56 per Unit, subject to adjustment. Subject to the provisions of the Rights Agreement, including certain exceptions specified therein, a distribution date for the Rights (the “Distribution Date”) will occur upon the earlier of (i) 10 business days following a public announcement that a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired or otherwise obtained beneficial ownership of 15% or more of the then‑outstanding shares of the Company’s common stock, and (ii) 10 business days (or such later date as may be determined by the Company’s board of directors) following the commencement of a tender offer or exchange offer that would result in a person or group becoming an Acquiring Person. The Rights are not exercisable until the Distribution Date and, unless earlier redeemed or exchanged by the Company pursuant to the terms of the Rights Agreement, will expire on the earlier of (i) the close of business on April 17, 2018, the first anniversary of the adoption of the Rights Agreement, and (ii) the date of any settlement, adjudication, dismissal with prejudice, abandonment by the Company or other conclusive and final resolution of the Company’s legal proceedings against SK hynix (see Note 7). In connection with the adoption of the Rights Agreement, the Company’s board of directors approved a Certificate of Designation of the Series A Preferred Stock (the “Certificate of Designation”) designating 1,000,000 shares of its serial preferred stock as Series A Preferred Stock and setting forth the rights, preferences and limitations of the Preferred Stock. The Company filed the Certificate of Designation with the Secretary of State of the State of Delaware on April 17, 2017 . On April 16, 2018, the Company entered into an amendment (the “Amendment”) to the Rights Agreement, which amended the definition of “Expiration Date” in the Rights Agreement to incorporate all of the Company’s legal proceedings against SK hynix, and amended the definition of “Final Expiration Date” in the Rights Agreement to mean the close of business on April 17, 2019. On April 17, 2019, the Company entered into a second amendment (the “Second Amendment”) to the Rights Agreement, which further amended the definition of “Expiration Date” in the Rights Agreement to extend the final expiration for an additional two years to April 17, 2021. As a result, the Rights will expire and become unexercisable on or before the close of business on April 17, 2021. Common Stock Purchase Agreement On June 24, 2019, the Company entered into the Purchase Agreement with Lincoln Park, pursuant to which the Company has the right to sell to Lincoln Park up to an aggregate of $10 million in shares of its common stock subject to the conditions and limitations set forth in the Purchase Agreement. As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park 818,420 shares of its common stock as initial commitment shares in a noncash transaction on June 24, 2019 and will issue up to 818,420 additional shares of its common stock as additional commitment shares on a pro rata basis in connection with any additional purchases. The Company will not receive any cash proceeds from the issuance of these additional commitment shares. During the three and nine months ended September 28, 2019, Lincoln Park purchased an aggregate of 8,189,364 shares of the Company’s common stock for a net purchase price of $2.5 million. In connection with the purchases, the Company issued to Lincoln Park an aggregate of 204,771 shares of its common stock as additional commitment shares in a noncash transaction. Pursuant to the Purchase Agreement, on any business day and as often as every other business day over the 36-month term of the Purchase Agreement, the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 400,000 shares of its common stock, with such amount increasing as the closing sale price of its common stock increases; provided Lincoln Park’s obligation under any single such purchase will not exceed $1.0 million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a “Regular Purchase”). If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park to purchase an additional amount of common stock that may not exceed the lesser of (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of the total number of shares of its common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement (“Accelerated Purchase”). Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple Accelerated Purchases on the same trading day. Subsequent to September 28, 2019, Lincoln Park purchased an aggregate of 9,655,398 shares of the Company’s common stock for a net purchase price of $3.5 million. In connection with the purchases, the Company issued to Lincoln Park an aggregate of 283,506 shares of its common stock as additional commitment shares in a noncash transaction. The Company controls the timing and amount of any sales of its common stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for the Company’s common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the Purchase Agreement if that would result in Lincoln Park beneficially owning more than 9.99% of its common stock. The Purchase Agreement does not limit the Company’s ability to raise capital from other sources at the Company’s sole discretion, except that, subject to certain exceptions, the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company. Warrants As of September 28, 2019, there were outstanding warrants to purchase an aggregate of 15,010,012 shares of the Company’s common stock with a weighted-average exercise price of $0.62. There were no activities during the nine months ended September 28, 2019.

Stock-Based Awards

Stock-Based Awards	9 Months Ended
	Sep. 28, 2019
Stock-Based Awards
Stock-Based Awards	Note 9—Stock-Based Awards Subject to certain adjustments, as of September 28, 2019, the Company was authorized to issue a maximum of 13,805,566 shares of its common stock pursuant to awards granted under its Amended and Restated 2006 Incentive Plan (“Amended 2006 Plan”). As of September 28, 2019, the Company had 1,160,322 shares of common stock available for issuance pursuant to future awards to be granted under the Amended 2006 Plan. Stock Options Stock options granted under the Amended 2006 Plan generally vest at a rate of at least 25% per year over four years and expire 10 years from the date of grant. The following table summarizes the Company’s stock option activities during the nine months ended September 28, 2019: Weighted- Number of Average Shares Exercise (in thousands) Price Outstanding at December 29, 2018 8,186 $ 1.18 Granted 595 0.35 Exercised (62) 0.36 Expired or forfeited (1,182) 1.02 Outstanding at September 28, 2019 7,537 1.15 Restricted Stock Awards Restricted stock vests annually on each anniversary of the grant date over a two-year term. RSUs granted for employees and consultants generally vest semi-annually from the grant date over a four-year term, and RSUs granted for independent directors fully-vest on the grant-date. The activities of all restricted stock awards during the nine months ended September 28, 2019 are as follows: Weighted- Average Number of Grant-Date Shares Fair Value (in thousands) per Share Outstanding at December 29, 2018 525 $ 0.25 Granted 3,727 0.55 Vested (1,012) 0.47 Forfeited (113) 0.54 Outstanding at September 28, 2019 3,127 0.52 Stock-Based Compensation Expense The following table summarizes the stock-based compensation expense by line item in the condensed consolidated statements of operations (in thousands): Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Cost of sales $ 6 $ 7 $ 20 $ 19 Research and development 67 46 163 182 Selling, general and administrative 170 104 599 370 Total $ 243 $ 157 $ 782 $ 571 As of September 28, 2019, the Company had approximately $1.8 million, net of estimated forfeitures, of unearned stock-based compensation, which it expects to recognize over a weighted-average period of approximately 3.0 years.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 28, 2019
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 29, 2018, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 22, 2019. In the opinion of management, all adjustments for the fair presentation of the Company’s condensed consolidated financial statements have been made. The adjustments are of a normal recurring nature except as otherwise noted. The results of operations for the interim periods are not necessarily indicative of the results to be expected for other periods or the full fiscal year. The Company has evaluated events occurring subsequent to September 28, 2019, through the filing date of this Quarterly Report on Form 10-Q and concluded that there were no events that required recognition and disclosures, other than those discussed elsewhere in the notes hereto.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Netlist, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Fiscal Year	Fiscal Year The Company operates under a 52 or 53 week fiscal year ending on the Saturday closest to December 31. For 2019, the Company’s fiscal year is scheduled to end on December 28, 2019 and will consist of 52 weeks, and each of the Company’s quarters within such fiscal year will be comprised of 13 weeks.
Use of Estimates	Use of Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results may differ materially from those estimates.
Revenue Recognition	Revenue Recognition Revenue is recognized when control is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods and services. Revenue recognition is evaluated through the five steps outlined within the guidance. Substantially all of the Company’s net sales relate to products sold at a point in time through ship-and-bill performance obligations. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Contracts with customers are comprised of customer purchase orders, invoices (including the Company’s standard terms and conditions) and written contracts. Performance Obligations Net sales and related cost of sales are primarily the result of promises to transfer products to customers. For performance obligations related to substantially all of the ship-and-bill products, control transfers at a point in time when title transfers upon shipment of the product to the customer, and for some sales, control transfers when title is transferred at time of receipt by the customer. Once a product has shipped or has been delivered, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to have transferred upon shipment or delivery, because the Company has a present right to payment at that time, the customer has legal title to the asset, the Company has transferred physical possession of the asset, and the customer has the significant risks and rewards of ownership of the asset. Amounts billed to its customers for shipping and handling are recorded in net product revenues. Shipping and handling costs incurred by the Company are included in cost of sales in the accompanying condensed consolidated statements of operations. Significant Payment Terms For ship-and-bill type contracts with customers, the invoice states the final terms of the sale, including the description, quantity, and price of each product purchased. Payment terms are typically due within 30 days after delivery but, in limited instances, can range up to 60 days after delivery. Accordingly, the Company’s contracts with customers do not include a significant financing component. Variable Consideration Customers are generally allowed limited rights of return for up to 30 days, except for sales of excess component inventories, which contain no right-of-return privileges. Product returns give rise to variable consideration that decreases the transaction price. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the anticipated performance and all information (historical, current and forecasted) that is reasonably available. Returns for products sold are estimated using the expected value method and are recorded as a reduction in reported revenues at the time of sale based upon historical product return experience and is adjusted for known trends to arrive at the amount of consideration to which the Company expects to receive. Estimated amounts are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Warranties The Company offers standard product warranties generally ranging from one to three years to its memory subsystem products customers, depending on the negotiated terms of any purchase agreements, and has no other post-shipment obligations or separately priced extended warranty or product maintenance contracts. These warranties require the Company to repair or replace defective product returned to the Company during the warranty period at no cost to the customer. Warranties are not offered on sales of component products. The Company records an estimate for warranty related costs at the time of sale based on its historical and estimated future product return rates and expected repair or replacement costs. Estimated future warranty costs are recorded in the period in which the sale is recorded and are included in cost of sales in the accompanying condensed consolidated statements of operations.
Leases	Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, accrued expenses and other current liabilities, and operating lease liabilities on its condensed consolidated balance sheets. Finance leases are included in property and equipment, accrued expenses and other current liabilities, and other liabilities in its condensed consolidated balance sheets. ROU assets represent the right of the Company to use an underlying asset for the lease term and lease liabilities represent the obligation of the Company to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. The Company does not present short-term leases on the balance sheet, as those leases have a lease term of twelve months or less at inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise.
Fair Value Measurements	Fair Value Measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. The Company categorizes each of its fair value measurements in one of those three levels based on the lowest level input that is significant to the fair value measurement in its entirely. · Level 1 – inputs are based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. · Level 2 – inputs are based on quoted prices of similar instruments in active markets, quoted prices for identical or similar instruments in market that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. · Level 3 – inputs are generally unobservable inputs for the asset or liability, which are typically based on management’s estimates of assumptions that market participants would use in pricing the assets and liabilities. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. The Company’s financial instruments consist principally of cash and cash equivalents, restricted cash, a revolving line of credit, and convertible promissory notes. The Company considers the carrying values of cash and cash equivalents and restricted cash to approximate the fair value for these financial instruments based upon an evaluation of the underlying characteristics, market data and because of the short period of time between origination of the instruments and their expected realization. The Company estimates the fair values of its revolving line of credit and convertible promissory notes by using current applicable rates for similar instruments as of the balance sheet date and an assessment of its credit rating. The carrying value of the Company’s revolving line of credit at September 28, 2019 and December 29, 2018 approximates fair value because the Company’s interest rate yield is near current market rates for comparable debt instruments. The Company estimates the fair value of its convertible promissory notes by using a discounted cash flow analysis using borrowing rates available to the Company for debt instruments with similar terms and maturities. The Company has determined that the valuation of its convertible promissory notes is classified in Level 2 of the fair value hierarchy. The carrying value and estimated fair value of a senior secured convertible promissory note as of September 28, 2019 were $14.5 million and $11.7 million, respectively. The carrying value and estimated fair value of a senior secured convertible promissory note as of December 29, 2018 were $14.3 million and $11.7 million, respectively. The carrying value and estimated fair value of the unsecured convertible note were $1.0 million and $0.7 million, respectively, as of September 28, 2019. The carrying value and estimated fair value of the unsecured convertible note were $2.0 million and $1.7 million, respectively, as of December 29, 2018.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents, and accounts receivable. The Company invests its cash equivalents primarily in money market mutual funds. Cash equivalents are maintained with high quality institutions, the composition and maturities of which are regularly monitored by management. At times, deposits held with financial institutions may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation and the Securities Investor Protection Corporation. The Company’s trade accounts receivable are primarily derived from sales to OEMs in the server, high-performance computing and communications markets, as well as from sales to storage customers, appliance customers, system builders and cloud and datacenter customers. The Company performs credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary, but generally requires no collateral. The Company believes the concentration of credit risk in its trade receivables is moderated by its credit evaluation process, relatively short collection terms, a high level of credit worthiness of its customers (see Note 3), foreign credit insurance, and letters of credit issued in its favor. Reserves are maintained for potential credit losses, and such losses historically have not been significant and have been within management’s expectations.
Stock-Based Compensation	Stock-Based Compensation Stock-based awards are comprised principally of stock options, restricted stock and restricted stock units (“RSUs”). Stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period, which is the vesting period, on a straight-line basis, net of estimated forfeitures. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of stock options. The model requires the Company to estimate the expected volatility and expected term of the stock options, which are highly complex and subjective variables. The expected volatility is based on the historical volatility of the Company’s common stock. The expected term is computed using the simplified method as the Company’s best estimate given its lack of actual exercise history. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the expected term of the grant effective as of the date of the grant. The expected dividend assumption is based on the Company’s history and management’s expectation regarding dividend payouts. The grant-date fair value of restricted stock and RSUs equals the closing price of the Company’s common stock on the grant date.
Net Loss Per Share	Net Loss Per Share The Company computes net loss per share using the two-class method required for participating securities. The Company considers restricted stock awards to be participating securities because holders of such shares have nonforfeitable dividend rights in the event of the Company’s declaration of a dividend for common shares. Under the two-class method, undistributed earnings are allocated to common stock and the participating securities according to their respective participating rights in undistributed earnings, as if all the earnings for the period had been distributed. No allocation of undistributed earnings to participating securities was performed for periods with net losses as such securities do not have a contractual obligation to share in the losses of the Company. Basic net loss per share is calculated by dividing net loss by the weighted-average common shares outstanding during the period following the two-class method. Diluted net loss per share is calculated by dividing the net loss by the weighted-average shares and dilutive potential common shares outstanding during the period. Dilutive potential shares consist of dilutive shares issuable upon the exercise of outstanding stock options and warrants computed using the treasury stock method, shares issuable under the conversion feature of convertible notes using the “if-converted” method, and shares issuable upon the vesting of restricted stock awards. In periods of losses, basic and diluted loss per share are the same, as the effect of stock options, warrants, convertible notes and unvested restricted stock awards on loss per share is anti-dilutive.
Adoption of New Accounting Pronouncements	Adoption of New Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), as amended ("ASC 842"), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. The Company adopted ASC 842 effective December 30, 2018 using a modified retrospective method and did not restate comparative periods. As permitted under the transition guidance, the Company carried forward the assessment of whether its contracts contain or are leases, classification of its leases and remaining lease terms. The Company also used hindsight in determining lease terms. Based on the lease portfolio as of December 30, 2018, the Company recognized approximately $1.5 million of operating lease right-of-use assets and operating lease liabilities on its condensed consolidated balance sheet upon adoption, primarily relating to real estate. No adjustments were required to be made to accumulated deficit upon adoption.
Recent Accounting Pronouncements	Recently Issued Accounting Pronouncements In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force) , which amends the accounting for implementation, setup, and other upfront costs in a hosting arrangement that is a service contract. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted including adoption in any interim period. The Company does not expect a significant impact as a result of adopting this update on its consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement , which removes, modifies, and adds various disclosure requirements on fair value measurements in Topic 820. ASU 2018-13 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted upon issuance of this update. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company does not expect a significant impact as a result of adopting this update on its consolidated financial statements.

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	9 Months Ended
	Sep. 28, 2019
Supplemental Financial Information
Schedule Of Inventories	September 28, December 29, 2019 2018 Raw materials $ 843 $ 1,072 Work in process 23 25 Finished goods 1,532 1,849 $ 2,398 $ 2,946
Schedule Of Computation Of Net Loss Per Share	Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Net loss per share — basic and diluted: Numerator: Net loss $ (3,108) $ (4,644) $ (10,677) $ (12,734) Denominator: Weighted-average common shares outstanding—basic and diluted 148,058 115,402 142,624 96,516 Net loss per share—basic and diluted $ (0.02) $ (0.04) $ (0.07) $ (0.13)
Schedule Of Potential Common Shares Excluded From The Diluted Net Loss Per Share Calculations	Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Weighted average common share equivalents 16,120 15,125 16,212 13,506
Schedule of Disaggregation of Sales by Major Source	Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Resales of third-party products $ 5,180 $ 5,089 $ 13,725 $ 18,531 Sale of the Company's modular memory subsystems 936 2,114 3,008 5,977 Total net sales $ 6,116 $ 7,203 $ 16,733 $ 24,508
Schedule of Sales from Customers	Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Customer: Customer A 13 % 16 % 11 % 19 % Customer B 10 % * % * % * % Customer C * % 12 % * % * % Customer D * % 11 % * % * % Customer E * % 11 % * % * % *
Schedule Of Supplemental Disclosures Of Cash Flow Information And Non-Cash Financing Activities	Nine Months Ended September 28, September 29, 2019 2018 Common stock issued on conversion of convertible note payable and accrued interest $ 1,417 $ — Debt financing of insurance $ — $ 344

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 28, 2019
Debt
Schedule Of Long-Term Debt	September 28, December 29, 2019 2018 Senior secured convertible note, due December 2021, including accrued interest of $1,159 (2019) and $934 (2018), respectively $ 16,159 $ 15,934 Unsecured convertible note, due August 2020, including accrued interest of $1 (2019) and $62 (2018) 1,022 2,332 Note payable — 376 Unamortized debt discounts and issuance costs (519) (920) 16,662 17,722 Less: current portion (997) (376) $ 15,665 $ 17,346

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 28, 2019
Leases
Schedule of lease cost and supplemental cash flow information relating to operating leases	Three Months Ended Nine Months Ended September 28, September 28, 2019 2019 Lease cost Operating lease cost $ 158 $ 476 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 155 $ 450 Right-of-use assets obtained in exchange for lease obligations Finance leases $ — $ 96
Schedule of supplemental balance sheet information	September 28, (in thousands) 2019 Operating Leases Operating lease right-of-use assets $ 1,133 Accrued expenses and other current liabilities $ 550 Operating lease liabilities 630 Total operating lease liabilities $ 1,180 Finance Leases Property and equipment, at cost $ 96 Accumulated depreciation (9) Property and equipment, net $ 87 Accrued expenses and other current liabilities $ 18 Other long-term liabilities 70 Total finance lease liabilities $ 88 Weighted Average Remaining Lease Term (in years) Operating lease 2.2 Finance lease 4.5 Weighted Average Discount Rate Operating lease 7.7 % Finance lease 5.1 %
Schedule of maturities of operating lease liabilities	Fiscal Year Operating Leases Finance Leases 2019 (remaining 3 months) $ 157 $ 5 2020 596 22 2021 376 22 2022 163 22 2023 — 22 Thereafter — 5 Total lease payments 1,292 98 Less: imputed interest (112) (10) Total $ 1,180 $ 88
Schedule of maturities of finance lease liabilities	Maturities of lease liabilities as of September 28, 2019 were as follows (in thousands): Fiscal Year Operating Leases Finance Leases 2019 (remaining 3 months) $ 157 $ 5 2020 596 22 2021 376 22 2022 163 22 2023 — 22 Thereafter — 5 Total lease payments 1,292 98 Less: imputed interest (112) (10) Total $ 1,180 $ 88
Schedule of future minimum lease payments under operating lease	Fiscal Year Amount 2019 $ 399 2020 208 Total minimum lease payments $ 607

Stock-Based Awards (Tables)

Stock-Based Awards (Tables)	9 Months Ended
	Sep. 28, 2019
Stock-Based Awards
Schedule Of Common Stock Options Activity	Weighted- Number of Average Shares Exercise (in thousands) Price Outstanding at December 29, 2018 8,186 $ 1.18 Granted 595 0.35 Exercised (62) 0.36 Expired or forfeited (1,182) 1.02 Outstanding at September 28, 2019 7,537 1.15
Schedule Of Restricted Stock Awards	Weighted- Average Number of Grant-Date Shares Fair Value (in thousands) per Share Outstanding at December 29, 2018 525 $ 0.25 Granted 3,727 0.55 Vested (1,012) 0.47 Forfeited (113) 0.54 Outstanding at September 28, 2019 3,127 0.52
Schedule of Stock-Based Compensation Expense	Three Months Ended Nine Months Ended September 28, September 29, September 28, September 29, 2019 2018 2019 2018 Cost of sales $ 6 $ 7 $ 20 $ 19 Research and development 67 46 163 182 Selling, general and administrative 170 104 599 370 Total $ 243 $ 157 $ 782 $ 571

Description of Business (Detail

Description of Business (Details) $ in Thousands	Jun. 24, 2019USD ($)	Sep. 28, 2019USD ($)	Jun. 29, 2019USD ($)	Mar. 30, 2019USD ($)	Sep. 29, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Sep. 28, 2019USD ($)segment	Sep. 29, 2018USD ($)	Dec. 29, 2018USD ($)	Dec. 30, 2017USD ($)
Number of reportable segment | segment								1
Net loss		$ (3,108)	$ (3,519)	$ (4,050)	$ (4,644)	$ (3,417)	$ (4,673)	$ (10,677)	$ (12,734)	$ 17,100	$ 13,400
Common Stock Purchase Agreement | Maximum
Issuance of commitment shares	$ 10,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Carrying value of convertible note	$ 997
Restricted cash	2,250	$ 1,850
Operating lease assets	1,133
Operating lease liabilities	1,180
Secured Debt [Member]
Carrying value of convertible note	14,500	14,300
Estimated fair value of convertible note	11,700	11,700
Unsecured Debt [Member]
Carrying value of convertible note	1,000	2,000
Estimated fair value of convertible note	$ 700	$ 1,700

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Warranty Liability) (Details)	9 Months Ended
	Sep. 28, 2019
Minimum
Product warranty period	1 year
Maximum
Product warranty period	3 years

Supplemental Financial Inform_3

Supplemental Financial Information (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Supplemental Financial Information
Raw materials	$ 843	$ 1,072
Work in process	23	25
Finished goods	1,532	1,849
Inventories	$ 2,398	$ 2,946

Supplemental Financial Inform_4

Supplemental Financial Information (Schedule Of Computation Of Net Loss Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 28, 2019	Sep. 29, 2018	Dec. 29, 2018	Dec. 30, 2017
Basic and diluted net loss per share:
Numerator: Net loss	$ (3,108)	$ (3,519)	$ (4,050)	$ (4,644)	$ (3,417)	$ (4,673)	$ (10,677)	$ (12,734)	$ 17,100	$ 13,400
Weighted-average common shares outstanding, basic and diluted	148,058			115,402			142,624	96,516
Basic and diluted net loss per share	$ (0.02)			$ (0.04)			$ (0.07)	$ (0.13)
Weighted average common share equivalents	16,120			15,125			16,212	13,506

Supplemental Financial Inform_5

Supplemental Financial Information (Disaggregation of Net Sales) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Net sales	$ 6,116	$ 7,203	$ 16,733	$ 24,508
Resales Of Third Party Products
Net sales	5,180	5,089	13,725	18,531
Sale of the Company's modular memory subsystems
Net sales	$ 936	$ 2,114	$ 3,008	$ 5,977

Supplemental Financial Inform_6

Supplemental Financial Information (Major Customers and Products) (Details) - customer	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018	Dec. 29, 2018
Sales Revenue, Resale of Products
Concentration Risk [Line Items]
Concentration Risk, Percentage	85.00%	82.00%	71.00%	76.00%
Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Number of Customers			2		2
Customer A | Sales Revenue, Product Line | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Percentage	13.00%	16.00%	11.00%	19.00%
Customer A | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Percentage			14.00%		22.00%
Customer B | Sales Revenue, Product Line | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	12.00%
Customer C | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Percentage			21.00%		15.00%
Customer D | Sales Revenue, Product Line | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Percentage		11.00%
Customer E | Sales Revenue, Product Line | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration Risk, Percentage		11.00%

Supplemental Financial Inform_7

Supplemental Financial Information (Schedule Of Supplemental Disclosures Of Cash Flow Information And Non-Cash Financing Activities) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018
Supplemental Financial Information
Common stock issued on conversion of convertible note payable and accrued interest	$ 1,417
Debt financing of insurance		$ 344

Credit Agreements (SVB Credit A

Credit Agreements (SVB Credit Agreement) (Narrative) (Details) - Silicon Valley Bank - USD ($) $ in Thousands	Oct. 31, 2009	Sep. 28, 2019	Dec. 29, 2018
Line of Credit Facility
Borrowing capacity as a percentage of eligible accounts receivable	80.00%	85.00%
Maximum borrowing capacity		$ 5,000
Outstanding borrowings		1,500	$ 2,300
Availability remaining		$ 100	200
Prime Rate
Line of Credit Facility
Debt instrument, basis spread on variable rate		2.75%
Letter of Credit
Line of Credit Facility
Outstanding borrowings		$ 2,300	$ 1,900

Debt (Schedule Of Long-Term Deb

Debt (Schedule Of Long-Term Debt) (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Debt
Notes Payable		$ 376
Unamortized debt discounts and issuance costs	$ (519)	(920)
Debt outstanding	16,662	17,722
Less: current portion	(997)	(376)
Long-term debt	15,665	17,346
Senior Secured Convertible Note Due December 2025 [member]
Debt
Debt outstanding, noncurrent portion	16,159	15,934
Accrued interest	1,159	934
Unsecured Convertible Note Due August 2020
Debt
Debt outstanding, noncurrent portion	1,022	2,332
Accrued interest	$ 1	$ 62

Debt (Narrative) (Details)

Debt (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 29, 2019	Aug. 27, 2018	Sep. 28, 2019	Sep. 28, 2019	Sep. 29, 2018	Nov. 18, 2015
Long-term debt
Original issue discount					$ 170
Exercise price of warrants (in dollars per share)			$ 0.62	$ 0.62
Debt issuance costs					23
Proceeds from issuance of debt, net of $170 discount					$ 2,100
SVIC Warrant
Long-term debt
Number of shares which may be purchased under warrant						2,000,000
Exercise price of warrants (in dollars per share)						$ 0.30
Fair value of warrants			$ 1,200	$ 1,200
Senior Secured Convertible Note Due December 2025 [member]
Long-term debt
Face amount						$ 15,000
Interest rate (as a percent)						2.00%
Debt conversion price (in dollars per share)						$ 1.25
Debt, net of discounts and costs			15,700	15,700
Unsecured Convertible Note Due August 2020
Long-term debt
Face amount		$ 2,300
Original issue discount		$ 200		200
Interest rate (as a percent)		8.00%
Debt conversion price (in dollars per share)		$ 0.36
Debt, net of discounts and costs		$ 1,000
Maximum Monthly Redemption Amount		$ 350
Lowest closing bid, percentage		85.00%
Redemption price floor, per share		$ 0.11
Maximum redemption amount honored		$ 150
Redemption conversion price		$ 0.06
Proceeds from Notes Payable				2,100
Debt issuance, liability component			1,900	1,900
Debt issuance, equity component		$ 200
Iliad Note [Member]
Long-term debt
Additional conversion of principal and accrued interest			$ 800	$ 900
Additional conversion of shares			3,247,000	3,624,074
Conversion of principal and accrued interest			$ 0	$ 500
Conversion of shares				1,388,890
Iliad Note [Member] | Subsequent Event
Long-term debt
Conversion of principal and accrued interest	$ 700
Conversion of shares	2,905,873

Leases - Lease Cost and Supplem

Leases - Lease Cost and Supplemental Cash Flow (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 28, 2019	Sep. 28, 2019
Lease, Cost [Abstract]
Operating lease cost	$ 158	$ 476
Operating cash flows from operating leases	$ 155	450
Finance leases		$ 96

Leases - Leases Supplemental Ba

Leases - Leases Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Sep. 28, 2019	Dec. 29, 2018
Lessee, Lease, Description [Line Items]
Operating lease assets	$ 1,133
Operating lease right-of-use assets - extensible list	us-gaap:OperatingLeaseRightOfUseAsset
Accrued expenses and other current liabilities	$ 550
Accrued expenses and other current liabilities - extensible list	us-gaap:AccruedLiabilitiesCurrent
Operating lease liabilities	$ 630
Operating lease liabilities - extensible list	us-gaap:OperatingLeaseLiabilityNoncurrent
Total	$ 1,180
Total operating lease liabilities - extensible list	us-gaap:AccruedLiabilitiesCurrent us-gaap:OperatingLeaseLiabilityNoncurrent
Property and equipment, net	$ 313	$ 279
Accrued expenses and other current liabilities	$ 18
Accrued expenses and other current liabilities - extensible list	us-gaap:AccruedLiabilitiesCurrent
Other liabilities	$ 70
Other liabilities - extensible list	us-gaap:OtherLiabilitiesNoncurrent
Finance Lease, Liability	$ 88
Total finance lease liabilities - extensible list	us-gaap:AccruedLiabilitiesCurrent us-gaap:OtherLiabilitiesNoncurrent
Finance leased assets
Lessee, Lease, Description [Line Items]
Property and equipment, at cost	$ 96
Accumulated depreciation	(9)
Property and equipment, net	$ 87

Leases - Weighted Average Remai

Leases - Weighted Average Remaining Lease Term (Details)	Sep. 28, 2019
Leases
Weighted average remaining lease term - Operating lease	2 years 2 months 12 days
Weighted Average Remaining Lease Term - Finance lease	4 years 6 months
Weighted Average Discount Rate - Operating lease	7.70%
Weighted Average Discount Rate - Finance lease	5.10%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 28, 2019USD ($)
Operating Lease Liabilities, Payments Due [Abstract]
2019 (remaining 3 months)	$ 157
2020	596
2021	376
2022	163
Total lease payments	1,292
Less: imputed interest	(112)
Total	1,180
Finance Lease Liabilities, Payments, Due [Abstract]
2019 (remaining 3 months)	5
2020	22
2021	22
2022	22
2023	22
Thereafter	5
Total lease payments	98
Less: imputed interest	(10)
Total	$ 88

Leases - Summary of Future Leas

Leases - Summary of Future Lease Payments Under Operating Lease (Details) $ in Thousands	Sep. 28, 2019USD ($)
Supplemental Financial Information
2019	$ 399
2020	208
Total minimum lease payments	$ 607

Commitments and Contingencies (

Commitments and Contingencies (Litigations and Patent Reexaminations) (Details)	Oct. 31, 2017patent	Sep. 01, 2016patent	Sep. 28, 2019USD ($)claimpatent	Dec. 29, 2018USD ($)	Dec. 30, 2017USD ($)
Commitments and Contingencies
Legal expenses excluded as a result of TRGP's payment of these expenses under the TRGP Agreement | $			$ 0	$ 1,800,000	$ 10,200,000
Inphi Litigation
Commitments and Contingencies
Number of patents claimed to be invalid			3
912 Patent Reexamination
Commitments and Contingencies
Number of claims rejected | claim			11
SK Hynix Litigation
Commitments and Contingencies
Number of patents infringed upon	2	6

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	Apr. 17, 2017	Sep. 28, 2019	Sep. 29, 2018	Jun. 29, 2019	Dec. 29, 2018
Serial Preferred Stock
Preferred Stock, Shares Authorized		10,000,000			10,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001
Preferred Stock, Shares Outstanding		0			0
Number of Rights Authorized for Each Outstanding Share of Stock	1
Number of Shares Issued when Right is Exercised	0.001
Purchase price per share	$ 6.56
Number of Days Rights are to be Distributed	10 days
Minimum Beneficial Ownership Percentage for Rights to be Distributed	15.00%
Common Stock
Common stock, shares authorized		300,000,000			300,000,000
Proceeds from issuance of common stock		$ 2,457	$ 15,764
Exercise price of warrants		$ 0.62
Stock-Based Compensation
Shares available for issuance				1,160,322
Shares authorized for issuance				13,805,566
Unearned stock-based compensation		$ 1,800
Weighted-average period over which unearned stock-based compensation is expected to be recognized		3 years
Series A Preferred Stock
Serial Preferred Stock
Preferred Stock, Shares Authorized		1,000,000			1,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001
Stock-Based Compensation
Shares available for issuance	1,000,000

Stockholders' Equity (Common St

Stockholders' Equity (Common Stock Purchase Agreement) (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 29, 2019	Jun. 24, 2019	Apr. 16, 2018	Sep. 28, 2019	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 28, 2019
Assets Sold under Agreements to Repurchase [Line Items]
Term agreement			2 years
Net purchase price				$ 2,457	$ 11,152	$ 2,818	$ 1,794
Class of Warrant or Right, Outstanding				15,010,012				15,010,012
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.62				$ 0.62
Common Stock Purchase Agreement
Assets Sold under Agreements to Repurchase [Line Items]
Commitment shares		818,420
Repurchased shares				8,189,364				8,189,364
Repurchase of common stock price				$ 2,500				$ 2,500
Stock issued common stock								204,771
Purchase Agreement Term		36 months
Subsequent Event | Common Stock Purchase Agreement
Assets Sold under Agreements to Repurchase [Line Items]
Additional commitment shares	283,506
Shares issued	9,655,398
Net purchase price	$ 3,500
Threshold Percentage of Common Stock to be Sold	9.99%
Period After Purchase Agreement Not to Enter into Variable Rate Transaction	36 months
Terminated Agreement Cost	$ 0
Maximum | Common Stock Purchase Agreement
Assets Sold under Agreements to Repurchase [Line Items]
Aggregate amount		$ 10,000
Additional commitment shares		818,420
Threshold Number of Shares of Common Stock to be Issued		400,000
Threshold Value of Shares of Common Stock to be Issued Under Single Purchase		$ 1,000
Threshold Percentage of Number of Shares Issued Under Regular Purchase to Purchase Additional Amount of Common stock		300.00%
Threshold Percentage of Number of Shares of Common Stock to Purchase Additional Amount of Common stock		30.00%

Stock-Based Awards (Schedule Of

Stock-Based Awards (Schedule Of Stock Option Activity) (Details) shares in Thousands	9 Months Ended
	Sep. 28, 2019$ / sharesshares
Number of Shares
Options outstanding, Number of Shares, Beginning Balance | shares	8,186
Options granted, Number of Shares | shares	595
Options exercised, Number of Shares | shares	(62)
Options expired/forfeited, Number of Shares | shares	(1,182)
Options outstanding, Number of Shares, Ending Balance | shares	7,537
Weighted-Average Exercise Price
Options outstanding, Weighted-Average Exercise Price, Beginning Balance | $ / shares	$ 1.18
Options granted, Weighted-Average Exercise Price | $ / shares	0.35
Options exercised, Weighted-Average Exercise Price | $ / shares	0.36
Options expired/forfeited, Weighted Average Exercise Price | $ / shares	1.02
Options outstanding, Weighted-Average Exercise Price, Ending Balance | $ / shares	$ 1.15

Stock-Based Awards (Schedule _2

Stock-Based Awards (Schedule of Restricted Stock Awards) (Details) shares in Thousands	9 Months Ended
	Sep. 28, 2019$ / sharesshares
Number of Shares
Balance nonvested, Number of Shares, Beginning Balance | shares	525
Granted, Number of Shares | shares	3,727
Vested, Number of Shares | shares	(1,012)
Forfeited, Number of Shares | shares	(113)
Balance nonvested, Number of Shares, Ending Balance | shares	3,127
Weighted-Average Exercise Price
Balance nonvested, Weighted-Average Grant-Date Fair Value per Share, Beginning Balance | $ / shares	$ 0.25
Granted, weighted-average grant date fair value | $ / shares	0.55
Vested, Weighted-Average Grant-Date Fair Value per Share | $ / shares	0.47
Forfeited, Weighted-Average Grant-Date Fair Value per Share | $ / shares	0.54
Balance nonvested, Weighted-Average Grant-Date Fair Value per Share, Ending Balance | $ / shares	$ 0.52
Vests annually on each anniversary | Restricted Stock
Weighted-Average Exercise Price
Vesting period	2 years
Vest semi-annually | Employees and consultants | Restricted Stock
Weighted-Average Exercise Price
Vesting period	4 years

Stock-Based Awards (Schedule _3

Stock-Based Awards (Schedule of Stock-Based Compensation Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2019	Sep. 29, 2018	Sep. 28, 2019	Sep. 29, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 243	$ 157	$ 782	$ 571
Unearned stock-based compensation	1,800		$ 1,800
Expects to recognize over a weighted-average period			3 years
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	6	7	$ 20	19
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	67	46	163	182
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 170	$ 104	$ 599	$ 370